FDA Blasted Over Shared Risk Plans For Brand, Generic Cos.
By Jeff Overley ( May 28, 2013, 9:53 PM EDT) -- The U.S. Food and Drug Administration has left pharmaceutical companies exposed to antitrust enforcement and product liability suits by failing to explain clearly how brand-name drugmakers and generics companies can negotiate shared risk-reduction plans for certain medicines, Prometheus Laboratories Inc. charged in a citizen petition released Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.